Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
Clinical trial NCT06754267 · RECRUITING
Trial details
- NCT number
- NCT06754267
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-01
- Primary completion
- 2025-12-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.